NCT04490135 is a NA clinical trial of Group psychotherapy in Carer Stress Syndrome, sponsored by Mount Sinai Hospital, Canada.

Who is sponsoring NCT04490135?

NCT04490135 is sponsored by Mount Sinai Hospital, Canada.

What drugs are being tested in NCT04490135?

Interventions in NCT04490135: Group psychotherapy.

What condition does NCT04490135 study?

NCT04490135 studies Carer Stress Syndrome.

Is NCT04490135 still recruiting?

NCT04490135 is currently completed. Last updated 29 July 2020.

Last reviewed 2020-07-29 · How we verify

NCT04490135

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of the Reitman Centre CARERS Group Intervention on Family Caregivers of Persons With Dementia

Completed NA Last updated 29 July 2020

What this trial tests

NA trial testing Group psychotherapy in Carer Stress Syndrome in 264 participants. Completed in 31 December 2017.

Timeline

1 January 2013

Primary endpoint
30 September 2017

31 December 2017

Quick facts

Lead sponsor	Mount Sinai Hospital, Canada
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	264
Start date	1 January 2013
Primary completion	30 September 2017
Estimated completion	31 December 2017
Sites	1 location across Canada

Drugs / interventions tested

Group psychotherapy

Conditions studied

Carer Stress Syndrome — all drugs for Carer Stress Syndrome →

Sponsor

Mount Sinai Hospital, Canada

Who can join

18 and older, any sex, with Carer Stress Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Family caregivers (CG) of persons with dementia are vulnerable to disproportionate physical, mental and social adverse health consequences . The Reitman Centre CARERS program is an innovative, group psychotherapeutic skills-training intervention. Study objective: to determine the effectiveness of the Reitman Centre CARERS program on key outcomes in family CGs of people with dementia. Study sample: Family CGs of people with dementia (n=264) referred to Reitman Center and the partner sites and wait-list control group (n=83) who received regular care. Method: quasi-experimental, non-randomized, multiple group trial; participants were evaluated before and after completion of the 8-week CARERS program in comparison.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A quasi-experimental study of the effectiveness of the Reitman Centre CARERS group intervention on family caregivers of persons with dementia.
Sadavoy J, Sajedinejad S, Chiu M. · · 2021 · cited 5× · PMID 33271636 · DOI 10.1002/gps.5481

Verify or expand the search:

Other trials of Group psychotherapy

Trials testing the same drug.

NCT05314556 — Group Psychotherapy in Narcolepsy Type 1 · NA · completed
NCT04672616 — Inklusiv Plus: Mental Health Of Unemployed Adolescents And Young Adults · NA · completed

Other recruiting trials for Carer Stress Syndrome

Currently open trials in the same condition.

NCT06624397 — Evaluation of a New Program for Carers of People with Anorexia Nervosa · NA · recruiting

Other Mount Sinai Hospital, Canada trials

Trials by the same sponsor.

NCT07272460 — Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME Trial · NA · recruiting
NCT07046572 — Methoxyflurane for IUD Insertion and Endometrial Biopsy · NA · recruiting
NCT06504277 — Low Versus Standard Pressure Pneumoperitoneum on Shoulder Tip Pain · NA · recruiting
NCT06546254 — 1% Lidocaine Paracervical Block for Endometrial Biopsy · NA · completed
NCT06733701 — The Use of Virtual Reality Technology During Oocyte Retrieval for in Vitro Fertilization · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04490135 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mount Sinai Hospital, Canada
Last refreshed: 29 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04490135.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing